Skip to main content

Table 5 Comparison of organ damage and failure related to DIC among the original and adjusted cohorts

From: The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study

  rhTM group Control group Original cohorts Adjusted cohorts
  (n = 37) (n = 29) Odds ratio (95 % CI)a P valuea Odds ratio (95 % CI)a P valuea
Cardiac, n (%) 1 (2.7) 1 (3.4) 0.778 (0.047–12.990) 0.861 0.970 (0.114–8.283) 0.978
Respiratory, n (%) 3 (8.1) 2 (6.9) 1.191 (0.186–7.645) 0.854 0.409 (0.115–1.460) 0.186
Renal, n (%) 3 (8.1) 3 (10.3) 0.765 (0.143–4.102) 0.754 0.737 (0.219–2.474) 0.621
Liver, n (%) 2 (5.4) 7 (24.1) 0.180 (0.034–0.944) 0.043 0.587 (0.216–1.595) 0.296
  1. aOdds ratio and P value estimated by logistic regression analysis. DIC disseminated intravascular coagulation, rhTM recombinant human soluble thrombomodulin